An engineered bacterial nitroreductase, NTR 2.0, improves chemically induced cell ablation, facilitating novel sustained ablation paradigms for testing the effects of chronic inflammation on regeneration, and modeling degenerative disease.
- Abigail V. Sharrock
- Timothy S. Mulligan
- Jeff S. Mumm